CPC A61K 39/39533 (2013.01) [A23C 9/123 (2013.01); A23G 3/36 (2013.01); A23G 3/364 (2013.01); A23G 4/06 (2013.01); A23G 4/12 (2013.01); A23G 9/32 (2013.01); A23G 9/36 (2013.01); A61K 31/133 (2013.01); A61K 31/4164 (2013.01); A61K 31/435 (2013.01); A61K 31/496 (2013.01); A61K 31/498 (2013.01); A61K 31/7048 (2013.01); A61K 33/00 (2013.01); A61K 39/3955 (2013.01); A61K 39/40 (2013.01); A61K 2039/505 (2013.01); Y02A 50/30 (2018.01)] | 24 Claims |
1. A method for treating or ameliorating a Crohn's Disease, a complication of a Crohn's Disease, or a Crohn's Disease-related fistulae, comprising administering to an individual in need thereof a therapeutic combination comprising:
(1) at least one anti-TNFα composition or drug; or at least one composition or drug capable of down-modulating or down-regulating a TNFα activity; and
(2) at least two anti-Mycobacterium avium sub species paratuberculosis (MAP) (an anti-MAP) agents.
|